Clinical evidence of improved biocompatibility using heparin-coated surfaces
- 1 May 1996
- journal article
- review article
- Published by SAGE Publications in Perfusion
- Vol. 11 (3) , 264-269
- https://doi.org/10.1177/026765919601100312
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Control of contact activation on end‐point immobilized heparin: The role of antithrombin and the specific antithrombin‐binding sequenceJournal of Biomedical Materials Research, 1995
- Biocompatibility of Heparin‐Coated Membrane Oxygenator During Cardiopulmonary BypassArtificial Organs, 1994
- THE COMPLEMENT SYSTEM IN TRAUMA-RELATED AND ISCHEMIC TISSUE DAMAGEShock, 1994
- Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass modelBlood Coagulation & Fibrinolysis, 1994
- More to “heparin” than anticoagulationThrombosis Research, 1994
- Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failureThe Annals of Thoracic Surgery, 1993
- Cardiopulmonary Bypass Using Centrifugal PumpVascular Surgery, 1992
- Reoperation and the centrifugal pump?European Journal of Cardio-Thoracic Surgery, 1992
- Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.Journal of Clinical Investigation, 1984